Tandem Diabetes Care | TNDM - Umsatzkosten

Aktienkurs
20.36
Täglich Wechseln
-0.32 -1.55%
Monatlich
-16.08%
Jährlich
12.74%
Q2 Prognose
19.92




Umsatzkosten Veränderung Datum
Abbott USD 5.3B 380M 2026-03
Accuray USD 116.17M 14.63M 2024-12
Align Technology USD 363.97M 7.48M 2025-12
AtriCure USD 35.16M 2.23M 2025-12
Baxter International USD 2.4B 512M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Boston Scientific USD 1.84B 82M 2025-12
Cooper Companies USD 376.8M 87.4M 2025-12
Dexcom USD 466.9M 11M 2025-12
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Eli Lilly USD 3.37B 363.7M 2025-12
Globus Medical USD 290.47M 8.09M 2025-12
ICU Medical USD 337.72M 1.61M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 215.2M 19M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
Intuitive Surgical USD 940.3M 21.6M 2026-03
J&J USD 8.07B 103M 2026-03
Masimo USD 165.2M 24.3M 2025-12
Medtronic USD 3.61B 83M 2025-12
Merit Medical Systems USD 198.58M 838K 2025-12
Orthofix International USD 66.63M 6.4M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Stryker USD 2.69B 373M 2025-12
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 261.54M 199.84M 2025-12
Zimmer Biomet Holdings USD 970.1M 234.3M 2025-12